GlassScriptPhysician profile
Jenna Selander
NPI 1891255410
$2,557.39
in general payments reported to CMS, 2019-2025
13 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $214 · 2023: $432 · 2024: $666 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $917.05 | 2022-2025 | Clareon, Lensx, Ngenuity |
| Bausch & Lomb Americas INC. | $353.83 | 2023-2025 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $346.86 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $187.04 | 2023-2024 | Vabysmo |
| Astellas Pharma US INC | $161.07 | 2025 | Izervay |
| Glaukos Corporation | $116.46 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $108.96 | 2021 | |
| Rayner Intraocular Lenses Limited | $89.96 | 2024 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Rxsight INC | $83.68 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Horizon Therapeutics Plc | $73.65 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $57.16 | 2024 | Eylea Hd |
| Mallinckrodt Hospital Products INC. | $37.82 | 2025 | Acthar |
| Thea Pharma INC. | $23.85 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Selander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.